Catalysts for Sogroya
9 tracked
Feb 27, 2026
approval
SOGROYA (SOMAPACITAN-BECO) — FDA approval
somatriptan albumin bound LA
→
Feb 27, 2026
approval
SOGROYA (SOMAPACITAN-BECO) — FDA approval
somatriptan albumin bound LA
→
Feb 27, 2026
approval
SOGROYA (SOMAPACITAN-BECO) — FDA approval
somatriptan albumin bound LA
→
Jul 9, 2025
approval
SOGROYA (SOMAPACITAN-BECO) — FDA approval
somatriptan albumin bound LA
→
Jan 31, 2025
approval
SOGROYA (SOMAPACITAN-BECO) — FDA approval
somatriptan albumin bound LA
→
Apr 28, 2023
approval
SOGROYA (SOMAPACITAN-BECO) — FDA approval
somatriptan albumin bound LA
→
Oct 1, 2021
approval
SOGROYA (SOMAPACITAN-BECO) — FDA approval
somatriptan albumin bound LA
→
Oct 1, 2021
approval
SOGROYA (SOMAPACITAN-BECO) — FDA approval
somatriptan albumin bound LA
→
Aug 28, 2020
approval
SOGROYA (SOMAPACITAN-BECO) — FDA approval
somatriptan albumin bound LA
→